Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (13)
  • Penn Non-Treatment Trials (10)
  • Phase 1: Solid Tumor Trials (2)
  • Proton Therapy Trials (1)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
NSABP-B-43 A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy and Radiation Therapy Alone for Women With HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy III Radiotherapy, Immunotherapy trastuzumab
RTOG 1005 A Phase III Trial of Accelerated Whole Breast Irradiation With Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer III Radiotherapy Not Applicable
CDR0000688097 A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients With Metastatic Breast Cancer III Radiation Therapy, Surgery Not Applicable
BO25126 A Randomized Multicenter, Double-blind, Placebo-controlled Comparison of Chemotherapy Plus Trastuzumab Plus Placebo Versus Chemotherapy Plus Trastuzumab Plus Pertuzumab as Adjuvant Therapy in Patients With Operable HER2-positive Primary Breast Cancer III Chemotherapy, Immunotherapy (Monoclonal Antibody) trastuzumab; pertuzumab
097517 I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2) II Immunotherapy, Signal Transduction Inhibitor trastuzumab; cyclophosphamide; paclitaxel; doxorubicin; neratinib; veliparib; figitumumab; trebananib; conatumumab
UPCC 03909 Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer II Signal Transduction Inhibitor PD 0332991
UPCC 02112 A Phase II Trial Of The JAK-Inhibitor Ruxolitinib (INCB018424) In Combination With Exemestane For Patients With Estrogen Receptor (ER) Positive Advanced Breast Cancer) II Hormonal Therapy exemestane; ruxolitinib
M12-895 A Randomized, Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination With Temozolomide or Veliparib in Combination With Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects With BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer II Chemotherapy, Signal Transduction Inhibitor carboplatin; temozolomide; paclitaxel; veliparib
UPCC 15107 A Randomized Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With DCIS I / II Immunotherapy HER-2/neu peptide vaccine
CA186-011 A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of BMS-663513 (Anti-CD137) in Subjects With Advanced and/or Metastatic Solid Tumors I Immunotherapy BMS-663513
UPCC 02111 A Phase 1 Trial of PD-0332991 and Paclitaxel in Patients With Rb-Expressing Advanced Breast Cancer I Chemotherapy, Signal Transduction Inhibitor paclitaxel; PD 0332991
UPCC 12110 The Effects of Radiation Therapy on the Reconstructed Breast: An Evaluation Using MR Imaging Not Specified Radiotherapy Not Applicable
UPCC 03111 A Study of hTERT/Survivin Multi-Peptide Vaccination With Basiliximab And Prevnar For Patients With Metastatic Breast Cancer Not Specified Immunotherapy basiliximab; prevnar
Displaying: 1 - 13 of 13 Results
  • < Previous
  • 1
  • Next >